Tamsulosin Hydrochloride Capsule
Product Images NDC 70518-0179

11 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 70518-0179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Tamsulosin Str)

Str (Tamsulosin Str)
Chemical structure of Tamsulosin Hydrochloride showing its molecular components and bonding arrangement as depicted in the image.*
FDA Label Image

Fig (Tamsulosin Fig1)

Fig (Tamsulosin Fig1)
A line graph depicting mean plasma concentrations of Tamsulosin Hydrochloride in ng/mL over time (hours) following a single 0.4 mg oral dose under fasted and fed conditions in eight subjects. The graph compares plasma concentration-time profiles for the drug under different nutritional states.*
FDA Label Image

Fig (Tamsulosin Fig2)

Fig (Tamsulosin Fig2)
A line graph titled 'Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1' showing mean change over treatment duration in weeks (0 to 13) plus LOCF for three groups: 0.8 mg treatment, 0.4 mg treatment, and placebo. The y-axis represents mean change values ranging from 0 to -11. The graph tracks symptom score reduction over time for the three groups, with distinct markers and lines for each treatment.*
FDA Label Image

Fig (Tamsulosin Fig3)

Fig (Tamsulosin Fig3)
A line graph showing mean change from baseline in total AUA symptom score over 13 weeks for a treatment study. The x-axis represents duration of treatment in weeks, and the y-axis shows mean change in symptom score. Three lines represent treatment groups: 0.8 mg dosage (circles), 0.4 mg dosage (triangles), and placebo (squares). Mean symptom scores decrease over time for all groups, with treatment groups showing greater reductions than placebo.*
FDA Label Image

Fig (Tamsulosin Fig4)

Fig (Tamsulosin Fig4)
A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1' showing mean change in mL/sec on the y-axis versus duration of treatment in weeks on the x-axis. It compares three treatments: 0.8 mg (circle markers), 0.4 mg (triangle markers), and placebo (square markers), depicting mean changes over periods from baseline through 13 weeks and last observation carried forward (LOCF).*
FDA Label Image

Fig (Tamsulosin Fig5)

Fig (Tamsulosin Fig5)
A line graph titled 'Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2' showing mean change in peak urine flow rate over a treatment duration of up to 13 weeks. It compares three treatments: 0.8 mg, 0.4 mg, and placebo, with mean change (mL/sec) on the y-axis and duration of treatment (weeks) on the x-axis. Treatment with 0.8 mg shows the highest mean increase, followed by 0.4 mg, then placebo over time.*
FDA Label Image

Mm1 (Tamsulosin HCl 0.4mg 70518 0179 00)

Mm1 (Tamsulosin HCl 0.4mg 70518 0179 00)
Tamsulosin Hydrochloride 0.4 mg capsule label showing quantity of 30 capsules. The capsules are green and orange, intended for oral use. The label includes NDC 70518-0179-00 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Storage instructions advise to avoid excessive moisture and to store at 20-25°C with permitted excursions to 15-30°C. Manufacturer is Rising Pharma, Inc., Allendale, NJ.*
FDA Label Image

Mm2 (Tamsulosin HCl 0.4mg 70518 0179 01)

Mm2 (Tamsulosin HCl 0.4mg 70518 0179 01)
Tamsulosin Hydrochloride 0.4 mg oral capsules label showing a quantity of 90 capsules. The label indicates prescription use only, NDC 70518-0179-01, manufactured by Rising Pharma, Inc., Allendale, NJ, and repackaged by RemedyRepack Inc., Indiana, PA. It includes storage instructions and advises users to see the package insert for directions.*
FDA Label Image

Mm3 (Tamsulosin HCl 0.4mg 70518 0179 02)

Mm3 (Tamsulosin HCl 0.4mg 70518 0179 02)
Label for Tamsulosin Hydrochloride 0.4 mg oral capsules showing quantity of 28. The label includes manufacturer as RemedyRepack Inc. and barcode, NDC number 70518-0179-02, along with storage instructions and directions to see package insert. The label features RemedyRepack logo in purple.*
FDA Label Image

Mm4 (Tamsulosin HCl 0.4mg 70518 0179 03)

Mm4 (Tamsulosin HCl 0.4mg 70518 0179 03)
Tamsulosin Hydrochloride 0.4 mg capsule label indicating a quantity of 100 capsules per box. Capsules are described as green and orange. The label includes storage instructions, manufacturer details (Rising Pharma, Inc.), and repackager information (RemedyRepack Inc., Indiana, PA). It is marked RX ONLY.*
FDA Label Image

Mm5 (Tamsulosin HCl 0.4mg 70518 0179 04)

Mm5 (Tamsulosin HCl 0.4mg 70518 0179 04)
Label for Tamsulosin Hydrochloride 0.4 mg capsule, count 1. The label includes NDC 70518-0179-04 and indicates the capsule colors as green and orange. It is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions recommend keeping out of reach of children and avoiding excessive moisture, with specified temperature conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.